Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Rituximab can cause skin issues, but baricitinib may help improve them.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Curcuma aeruginosa extract lotion significantly reduces underarm hair growth.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Facial hyperpigmentation improved with oral isotretinoin and ivermectin cream after Demodex mites were identified as the cause.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.